Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

blys antagonistic peptide ss12, fusion protein ss12‑fc containing the antagonistic peptide and gene

A fusion protein and antagonistic peptide technology, applied in the field of biomedicine, can solve problems such as low efficiency, unstable peptides, and short half-life

Inactive Publication Date: 2017-01-25
TIANJIN UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, peptides also have the disadvantages of instability, low efficiency and short half-life

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • blys antagonistic peptide ss12, fusion protein ss12‑fc containing the antagonistic peptide and gene
  • blys antagonistic peptide ss12, fusion protein ss12‑fc containing the antagonistic peptide and gene
  • blys antagonistic peptide ss12, fusion protein ss12‑fc containing the antagonistic peptide and gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Structural information on the interaction between BLyS and its receptors and the design of novel antagonistic peptides targeting BLyS

[0058] The interaction mode between BLyS and its receptor was explored by computer-aided molecular docking and dynamic simulation, and the key amino acid residues for mutual recognition between BLyS and its receptor were analyzed by means of computer graphics and distance geometry.

[0059] Using computer-aided molecular design and high-throughput virtual screening technology to de novo design short peptides that can simulate the conformation of key amino acids in receptors, and then theoretically evaluate the role of BLyS and antagonistic peptides by means of de novo construction, molecular docking, and kinetic simulation; use computer graphics Biochemical techniques, distance geometry, and intermolecular hydrogen bonding interactions were used to evaluate potential biological effects of antagonistic peptides. After theoretical screeni...

Embodiment 2

[0061] Plasmids SS12-Fc-pET30a and 3SS12-Fc-pET30a containing SS12-Fc and 3SS12-Fc fusion protein genes were constructed respectively ( figure 1 ).

[0062] 2.1 The gene encoding BLyS antagonistic peptide SS12 was constructed by the following method: According to the amino acid sequence of the antagonistic peptide SS12, we designed two DNA primers encoding short peptides, and ordered synthesis through the company.

[0063] The SS12 upstream primer is shown in SEQ ID NO.5, and the SS12 downstream primer is shown in SEQ ID NO.6

[0064] The synthetic SS12 DNA primer was dissolved in 200 μl of 10 mM Tris-Hcl (pH 8.5) (final concentration 16 pmol / μl). Take 20 μl of the positive and negative strands of the SS12 gene, mix them in EP tubes, boil in a water bath at 100°C for 3 minutes, and gradually cool down to room temperature. Use 2% agarose gel electrophoresis to observe the annealing result. The results of electrophoresis showed that there was an obvious band at 65bp ( figur...

Embodiment 3

[0078] Induction and expression of SS12-Fc and 3SS12-Fc fusion proteins

[0079] The correctly sequenced recombinant plasmids SS12-Fc-pET30a and 3SS12-Fc-pET30a were respectively transformed into the expression host strain E. coli. Under the condition of induction, the target protein can be induced. Select high-expression strains for mass expression, purify by protein A gel affinity chromatography, collect the eluate, dialyze in 1×PBS, measure and calculate the SS12-Fc protein concentration with a UV spectrophotometer to 700ng / μl, 3SS12 - Fc protein concentration is 1400 ng / μl. Get the target protein after dialysis and carry out SDS-PAGE electrophoresis, find, the size of SS12-Fc and 3SS12-Fc protein is respectively 25.4kDa and 28.6kDa, and SS12-Fc and 3SS12-Fc size are consistent, and have higher purity (see Figure 8 ).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses BLyS antagonistic peptide SS12, fusion protein SS12-Fc containing the antagonistic peptide and a gene. Experiments prove that SS12-Fc and 3SS12-Fc fusion protein can be combined with BLyS and interaction between BLyS and BCMA and interaction between BLyS and TACI are inhibited. SS12-Fc and 3SS12-Fc fusion protein guarantee the stability of spatial structures of SS12 and 3SS12 without weakening the activity of peptide, and SS12 and 3SS12 contain Fc tags and can be easily purified and detected, so that SS12-Fc and 3SS12-Fc, which serve as BLyS antagonists, can be applied to potential medicines for treating autoimmunity diseases and lymphoma.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to BLyS antagonistic peptides, fusion proteins, genes and plasmids containing BLyS antagonistic peptides. Background technique [0002] B lymphocyte stimulating factor (B lymphocyte stimulator, BLyS), also known as B cell activating factor (Bcell activating factor belonging to the TNF family, BAFF), is a member of the TNF family. It is continuously synthesized and secreted by monocytes and macrophages. BLyS can bind three receptors on the surface of B cells, B cell mature antigen (B cell mature antigen, BCMA), transmembrane activator and CAML conjugate (Transmembrane activator and CAML-interactor, TACI) and BLyS receptor 3 (BR3) . After the receptor binds to BLyS, it is coupled with TNF receptor associated factor (TRAF) to activate the NF-κB pathway. Finally, induce the expression of anti-apoptotic genes: Bcl-2, Bcl-xL, and reduce the apoptosis of mature B cells. If BLyS i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/08C07K19/00C12N15/62C12N15/70C12N15/66
Inventor 孙剑冯建男臧孟存沈倍奋
Owner TIANJIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com